Piramal Pharma Limited (NSE:PPLPHARMA)
India
· Delayed Price · Currency is INR 219.87
-3.75 (-1.68%)
Apr 24, 2025, 3:30 PM IST
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 296.46 billion as of April 24, 2025. Its market cap has increased by 65.69% in one year.
Market Cap
296.46B
Enterprise Value
340.24B
Revenue
89.49B
Ranking
n/a
PE Ratio
762.12
Stock Price
219.87
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 296.46B, an increase of 30.76%. That is a compound annual growth rate of 11.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 291.49B | -17.42% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,186.60B |
| Divi's Laboratories | 1,564.01B |
| Cipla | 1,223.70B |
| Mankind Pharma | 1,067.92B |
| Apollo Hospitals Enterprise | 1,026.98B |
| Zydus Lifesciences | 850.62B |
| Aurobindo Pharma | 697.66B |
| Alkem Laboratories | 592.24B |